According to Coherent Market Insights, the global cell therapy manufacturing market is estimated to be valued at US$ 3,755.4 million in 2022 and is expected to
/PRNewswire/ One of the key vendors operating in the immunology market is AbbVie Inc. The company offers an immunology product named HUMIRA. The market also.